accuracy of PMX on FNAC is low and varies from 21% to 44% in different studies. [7] In the present case, a retrospective analysis of the cytosmears revealed few groups of ghost cells, anucleated squamous epithelial cells, and occasional multinucleated giant cells admixed with the basaloid cells, which favored the diagnosis of pilomatricoma. However, on extensive search, no foci of calcification were noted.
accuracy of PMX on FNAC is low and varies from 21% to 44% in different studies. [7] In the present case, a retrospective analysis of the cytosmears revealed few groups of ghost cells, anucleated squamous epithelial cells, and occasional multinucleated giant cells admixed with the basaloid cells, which favored the diagnosis of pilomatricoma. However, on extensive search, no foci of calcification were noted.
To conclude, the present case highlights the importance of considering pilomatricoma as a differential diagnosis of any dermal/subcutaneous nodule in any age and locations other than head and neck. It also reiterates the fact that cytopathologists who play an important role in diagnosing such lesions should be aware of the variability of the cellular composition of these types of lesions to avoid misdiagnosis.
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Letter to Editor

Secretory Carcinoma Breast -The Characteristic Cytological Features in Diagnosis of This Rare Carcinoma
Sir,
Secretory carcinoma, also called as juvenile carcinoma, is a rare breast carcinoma with a frequency of 0.15% of all breast malignancy. [1, 2] The patients clinically present with an indolent, well-defined mobile breast lump leading to common clinical diagnosis of fibroadenoma. Because of the rarity of tumor, the diagnosis is often missed on FNAC. This case highlights the characteristic findings in cytology to clinch the diagnosis confidently on FNAC.
The patient was a 66-year-old female who presented with a breast lump, which was slowly increasing in size for the last 2 years. On examination, there was a well-defined firm, nontender mobile subareolar lump, 3.0 × 3.0 cm in size in left breast. The nipple and overlying skin were unremarkable. USG showed a 2.8 × 2.8 × 2.5 cm well-defined capsulated lobulated mass lesion with smooth borders and no axillary lymphadenopathy.
Fine needle aspiration revealed highly cellular smears, which consisted of numerous papillaroid fragments, loosely cohesive clusters, and singly lying atypical epithelial cells. These cells had abundant clear grape like vacuolated cytoplasm, eccentrically placed nuclei with mild pleomorphism, and inconspicuous nucleoli [ Figure 1 ]. There was presence of intra-and extracellular PAS -positive secretory material [ Figure 2 ]. There was no evidence of mitotic activity in the tumor cells. A possibility of secretory carcinoma of the breast was suggested.
The patient underwent simple mastectomy with axillary clearance. On gross examination, a well-circumscribed tumor with pushing margins was detected just beneath the areola. The tumor was 2.5 cm in diameter. On microscopic examination, an infiltrating carcinoma was seen. The tumor composed of solid, microcystic, tubular, and papillary areas [ Figure 3 ]. The cells were polygonal and there was presence of intra-and extracellular PAS -positive secretory material. Mitotic activity was minimal. None of the lymph node had metatstatic deposits. On immunohistochemistry, the tumor was negative for hormone receptors (triple negative for ER, PR, and Her-2neu) and was positive for Pan CK, EMA, and S-100. To confirm, ETV6-NTRK3 gene fusion (balanced translocation t (12; 15) resulting in an ETS variant 6-neurotrophic tyrosine kinase receptor3 fusion gene encoding a chimeric tyrosine kinase) was also done. [3] It was also positive. Hence, a final diagnosis of Secretory Carcinoma Breast was rendered. The patient was not given any chemotherapy. One year follow-up until now does not show any recurrence or metastasis.
Secretory carcinoma breast is a rare low-grade invasive carcinoma, which is composed of cells that produce intra-and extracellular secretory material. [3, 4] These tumors have an indolent clinical course and appear to have an excellent prognosis in patients under the age of 20 year. [2] However, in older patients, a more aggressive course is manifested with late recurrences.
Fine needle aspiration appears to be an excellent tool in diagnosing this rare carcinoma with confidence. [5] Typical features on cytology include highly cellular material, mild nuclear pleomorphism, and the presence of prominent intracytoplasmic vacuolation, which is the cytological hallmark of Secretory Carcinoma. [6] The presence of clear grape like clusters in the cytoplasm of the cells has been considered a distinctive feature for distinguishing Secretory Carcinoma from other benign and malignant breast lesions. [6] In the above described case, there was a striking similarity between the cytological and histopathological findings, the highly cellular papillary cores, and cells having abundant clear grape like vacuolated cytoplasm were characteristically seen in both. Our case was triple negative and showed no regional or distant metastasis. It also showed ETV6-NTRK3 gene fusion.
It is important to diagnose this tumor on FNAC so that patient can undergo simple mastectomy and sentinel node biopsy rather than going for a more debilitating modified radical mastectomy and axillary clearance. Thus, Secretory Carcinoma Breast can be diagnosed with confidence by FNAC and this helps in appropriate surgical management.
